Belgian Body Warns Over Price Erosion
More Than 3,000 Off-Patent Drugs Set For Price Cuts From April
Executive Summary
With well over 3,000 off-patent medicines set for a price cut from the start of April in Belgium, local industry association Medaxes has voiced its support for government-led healthcare cost efficiencies but has warned of the risks of driving players out of the market with unsustainably low prices.